A multicenter, prospective evaluation of quality of care and mortality in japan based on the surviving sepsis campaign guidelines

Journal of Infection and Chemotherapy

Volumn 20, Issue 2, 2014, Pages 115-120

  Fujishima, Seitaro ^a   Gando, Satoshi ^a   Saitoh, Daizoh ^a   Mayumi, Toshihiko ^a   Kushimoto, Shigeki ^a   Shiraishi, Shin Ichiro ^a   Ogura, Hiroshi ^a   Takuma, Kiyotsugu ^a   Kotani, Joji ^a   Ikeda, Hiroto ^a   Yamashita, Norio ^a   Suzuki, Koichiro ^a   Tsuruta, Ryosuke ^a   Takeyama, Naoshi ^a   Araki, Tsunetoshi ^a   Suzuki, Yasushi ^a   Miki, Yasuo ^a   Yamaguchi, Yoshihiro ^a   Aikawa, Naoki ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Emergency department; Intensive care unit; Japanese association for acute medicine; Quality indicator; Septic shock; Surviving sepsis campaign guidelines

Indexed keywords

GLUCOSE;

ABDOMINAL INFECTION; ACUTE LUNG INJURY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EMPYEMA; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE QUALITY; HUMAN; INTERNET; JAPAN; KIDNEY FAILURE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; PNEUMONIA; PRACTICE GUIDELINE; PROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SEVERE SEPSIS; SKIN INFECTION; SOFT TISSUE INFECTION; THROMBOCYTOPENIA; URINARY TRACT INFECTION;

EMERGENCY DEPARTMENT; INTENSIVE CARE UNIT; JAPANESE ASSOCIATION FOR ACUTE MEDICINE; QUALITY INDICATOR; SEPTIC SHOCK; SURVIVING SEPSIS CAMPAIGN GUIDELINES;

HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; JAPAN; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; SEPSIS; SHOCK, SEPTIC;

EID: 84903702323     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2013.09.003     Document Type: Article

References (25)

1. Sun D, Aikawa N. The natural history of the systemic inflammatory response syndrome and the evaluation of SIRS criteria as a predictor of severity in patients hospitalized through emergency services. Keio J Med 1999;48:28-37
2. Suka M, Yoshida K, Takezawa J. Incidence and outcome of sepsis in Japanese intensive care units: the Japanese nosocomial infection surveillance system. Environ Health Preventive Med 2006;11:298-303 (Pubitemid 44846588)
3. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004;30:536-55
4. Surviving Sepsis Campaign Website. Available from: www.survivingsepsis. org
5. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 2003;29:530-8
6. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101: 1644-55
7. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al. The Surviving Sepsis Campaign: results of an international guidelinebased performance improvement program targeting severe sepsis. Crit Care Med 2010;38:367-74
8. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B, Network CU- R. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003;168:165-72 (Pubitemid 36920969)
9. Blanco J, Muriel-Bombin A, Sagredo V, Taboada F, Gandia F, Tamayo L, et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008;12:R158
10. Tromp M, Tjan DH, van Zanten AR, Gielen-Wijffels SE, Goekoop GJ, van den Boogaard M, et al. The effects of implementation of the Surviving Sepsis Campaign in the Netherlands. Neth J Med 2011;69:292-8
11. Phua J, Koh Y, Du B, Tang YQ, Divatia JV, Tan CC, et al. Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ 2011;342:d3245
12. Lefrant JY, Muller L, Raillard A, Jung B, Beaudroit L, Favier L, et al. Reduction of the severe sepsis or septic shock associated mortality by reinforcement of the recommendations bundle: a multicenter study. Ann Fr Anesth Reanim 2010;29:621-8
13. Castellanos-Ortega A, Suberviola B, Garcia-Astudillo LA, Holanda MS, Ortiz F, Llorca J, et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med 2010;38:1036-43
14. Cardoso T, Carneiro AH, Ribeiro O, Teixeira-Pinto A, Costa-Pereira A. Reducing mortality in severe sepsis with the implementation of a core 6-hour bundle: results from the Portuguese community-acquired sepsis study (SACiUCI study). Crit Care 2010;14:R83
15. Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Diaz G, Garnacho-Montero J, et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008;299:2294-303 (Pubitemid 351724396)
16. Puskarich MA, Trzeciak S, Shapiro NI, Arnold RC, Horton JM, Studnek JR, et al. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med 2011;39:2066-71
17. Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010;38:1045-53
18. Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, et al. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 2009;180:861-6
19. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goaldirected therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77
20. Investigators N-S, Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-97
21. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39
22. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-61 (Pubitemid 43200296)
23. Investigators N-S, Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, et al. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012;367:1108-18
24. Hermanides J, Bosman RJ, Vriesendorp TM, Dotsch R, Rosendaal FR, Zandstra DF, et al. Hypoglycemia is associated with intensive care unit mortality. Crit Care Med 2010;38(6):1430-4
25. Ali NA, O'Brien Jr JM, Dungan K, Phillips G, Marsh CB, Lemeshow S, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008;36:2316-21.